156 related articles for article (PubMed ID: 31816924)
1. Deterioration in Muscle Mass and Physical Function Differs According to Weight Loss History in Cancer Cachexia.
Stene GB; Balstad TR; Leer ASM; Bye A; Kaasa S; Fallon M; Laird B; Maddocks M; Solheim TS
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31816924
[TBL] [Abstract][Full Text] [Related]
2. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
McDonald J; Sayers J; Anker SD; Arends J; Balstad TR; Baracos V; Brown L; Bye A; Dajani O; Dolan R; Fallon MT; Fraser E; Griel C; Grzyb A; Hjermstad M; Jamal-Hanjani M; Jakobsen G; Kaasa S; McMillan D; Maddocks M; Philips I; Ottestad IO; Reid KF; Sousa MS; Simpson MR; Vagnildhaug OM; Skipworth RJE; Solheim TS; Laird BJA;
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):1932-1948. PubMed ID: 37671529
[TBL] [Abstract][Full Text] [Related]
3. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
Katakami N; Uchino J; Yokoyama T; Naito T; Kondo M; Yamada K; Kitajima H; Yoshimori K; Sato K; Saito H; Aoe K; Tsuji T; Takiguchi Y; Takayama K; Komura N; Takiguchi T; Eguchi K
Cancer; 2018 Feb; 124(3):606-616. PubMed ID: 29205286
[TBL] [Abstract][Full Text] [Related]
4. Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).
Crawford J; Prado CM; Johnston MA; Gralla RJ; Taylor RP; Hancock ML; Dalton JT
Curr Oncol Rep; 2016 Jun; 18(6):37. PubMed ID: 27138015
[TBL] [Abstract][Full Text] [Related]
5. Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
Takayama K; Katakami N; Yokoyama T; Atagi S; Yoshimori K; Kagamu H; Saito H; Takiguchi Y; Aoe K; Koyama A; Komura N; Eguchi K
Support Care Cancer; 2016 Aug; 24(8):3495-505. PubMed ID: 27005463
[TBL] [Abstract][Full Text] [Related]
6. Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial.
Balstad TR; Brunelli C; Pettersen CH; Schønberg SA; Skorpen F; Fallon M; Kaasa S; Bye A; Laird BJA; Stene GB; Solheim TS
Front Nutr; 2020; 7():602775. PubMed ID: 33585533
[No Abstract] [Full Text] [Related]
7. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
[TBL] [Abstract][Full Text] [Related]
8. Gait speed is a biomarker of cancer-associated cachexia decline and recovery.
Roy I; Binder-Markey B; Sychowski D; Willbanks A; Phipps T; McAllister D; Bhakta A; Marquez E; D'Andrea D; Franz C; Pichika R; Dwinell MB; Jayabalan P; Lieber RL
bioRxiv; 2023 Nov; ():. PubMed ID: 38014165
[TBL] [Abstract][Full Text] [Related]
9. Are measures and related symptoms of cachexia recorded as outcomes in gastrointestinal cancer chemotherapy clinical trials?
Valaire R; Garden F; Razmovski-Naumovski V
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1146-1156. PubMed ID: 38533530
[TBL] [Abstract][Full Text] [Related]
10. What are the criteria for response to cachexia treatment?
Crawford J
Ann Palliat Med; 2019 Jan; 8(1):43-49. PubMed ID: 30685983
[TBL] [Abstract][Full Text] [Related]
11. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer.
Solheim TS; Laird BJA; Balstad TR; Stene GB; Bye A; Johns N; Pettersen CH; Fallon M; Fayers P; Fearon K; Kaasa S
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):778-788. PubMed ID: 28614627
[TBL] [Abstract][Full Text] [Related]
12. A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol.
Miura S; Naito T; Mitsunaga S; Omae K; Mori K; Inano T; Yamaguchi T; Tatematsu N; Okayama T; Morikawa A; Mouri T; Tanaka H; Kimura M; Imai H; Mizukami T; Imoto A; Kondoh C; Shiotsu S; Okuyama H; Ueno M; Takahashi T; Tsuji T; Aragane H; Inui A; Higashiguchi T; Takayama K
BMC Cancer; 2019 May; 19(1):528. PubMed ID: 31151425
[TBL] [Abstract][Full Text] [Related]
13. Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial).
Stewart Coats AJ; Ho GF; Prabhash K; von Haehling S; Tilson J; Brown R; Beadle J; Anker SD;
J Cachexia Sarcopenia Muscle; 2016 Jun; 7(3):355-65. PubMed ID: 27386169
[TBL] [Abstract][Full Text] [Related]
14. The relationship between muscle mass and function in cancer cachexia: smoke and mirrors?
Ramage MI; Skipworth RJE
Curr Opin Support Palliat Care; 2018 Dec; 12(4):439-444. PubMed ID: 30138131
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer.
Naito T; Okayama T; Aoyama T; Ohashi T; Masuda Y; Kimura M; Shiozaki H; Murakami H; Kenmotsu H; Taira T; Ono A; Wakuda K; Imai H; Oyakawa T; Ishii T; Omori S; Nakashima K; Endo M; Omae K; Mori K; Yamamoto N; Tanuma A; Takahashi T
BMC Cancer; 2017 Aug; 17(1):571. PubMed ID: 28841858
[TBL] [Abstract][Full Text] [Related]
16. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.
da Rocha IMG; Marcadenti A; de Medeiros GOC; Bezerra RA; Rego JFM; Gonzalez MC; Fayh APT
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):445-454. PubMed ID: 30924270
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of muscle strength and function in patients with cancer cachexia.
Gale N; Wasley D; Roberts S; Backx K; Nelson A; van Deursen R; Byrne A
Support Care Cancer; 2019 Jan; 27(1):131-137. PubMed ID: 29860710
[TBL] [Abstract][Full Text] [Related]
18. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis.
Vagnildhaug OM; Blum D; Wilcock A; Fayers P; Strasser F; Baracos VE; Hjermstad MJ; Kaasa S; Laird B; Solheim TS;
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):789-797. PubMed ID: 28627024
[TBL] [Abstract][Full Text] [Related]
19. FIT: Functional and imaging testing for patients with metastatic cancer.
Roeland EJ; Phull H; Hagmann C; Sera C; Dullea AD; El-Jawahri A; Nelson S; Gallivan A; Ma JD; Nipp RD; Baracos VE
Support Care Cancer; 2021 May; 29(5):2771-2775. PubMed ID: 32990784
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.
Gordon JN; Trebble TM; Ellis RD; Duncan HD; Johns T; Goggin PM
Gut; 2005 Apr; 54(4):540-5. PubMed ID: 15753541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
